Search
Regulatory Story
Company DeepMatter Group PLC
TIDM DMTR
Headline Interim Results
Released 07:00 19-Sep-2019
Number 8783M07

RNS Number : 8783M
DeepMatter Group PLC
19 September 2019
 

19 September 2019

 

DeepMatter Group plc

("DeepMatter", the "Company" or the "Group")

 

Interim Results

 

DeepMatter Group Plc, (AIM: DMTR), the AIM-listed company focusing on digitizing chemistry, announces its unaudited interim results for the six months ended 30 June 2019.

 

Operational Highlights:

·    Acquisition of InfoChem GmbH, a specialist in cheminformatics, for a total consideration of £2.03 million, with integration proceeding to plan

·    Board strengthened with the appointment of Bettina Goerner as a Non-Executive Director on 11 March 2019 and Lauren Lees appointed as Financial Director on 28 June 2019

·    David Cleevely and Professor Lee Cronin stepped down from the Board to be appointed as Chairman and member, respectively of the Advisory Committee

·    Pioneer Programme now largely complete with the DigitalGlasswareTM platform having been successfully deployed over approximately 12 months by seven organisations worldwide

·    First revenue-generating order for the DigitalGlassware™ platform from o2h discovery, a graduate of the Pioneer Programme, received post period end

·    Launch of the open access DigitalGlasswareTM online portal, allowing the scientific world to view and interact with shareable data

 

Financial Highlights:

·    Cash at 30 June 2019 of £4.08m (30 June 2018: £2.07m)

·    First period of revenue generation for the combined Group; £0.22m delivered

·    Loss of £1.62m after tax (H1 2018: £0.98m loss), primarily attributed to the one-off costs of the InfoChem acquisition

·    Equity placing at 2.5 pence per share raised gross cash proceeds of approximately £4.0m

·    Net assets at 30 June 2019 of £10.36m (30 June 2018: £7.14m)

 

Outlook

·    Promising ongoing discussions with regards to further DigitalGlasswareTM deployments

·    Confident in continued growth and successful execution of the long-term strategy

 

Mark Warne, Chief Executive Officer of DeepMatter, commented:

 

"DeepMatter has continued to deliver against its strategic roadmap by reaching several key milestones in the Group's journey. The imminent completion of our successful Pioneer Programme and the continued deployment of DigitalGlasswareTM demonstrates that the scientific community is embracing the move towards the digitization of chemistry and DeepMatter remains at the forefront of driving this vision.

 

"The acquisition of InfoChem and the additions to our team of experts has further enhanced our capabilities. We enter the second half of the year with a rapidly expanding pipeline of opportunities that will enable DeepMatter to further deploy our technology and focus on the continued monetisation of the platform. We remain confident about the future and, with a robust strategy in place, look forward to driving our vision and achieving our long-term objectives."

 

 

 

 For further information:

DeepMatter Group plc

T: 0141 548 8156

Mark Warne, Chief Executive Officer

 

 

 

 

Shore Capital (Nominated Adviser and Broker)

 

T:  020 7408 4050

Tom Griffiths

David Coaten

 

 

 

Alma PR

Caroline Forde

Rebecca Sanders-Hewett

Susie Hudson

Jessica Joynson

 

T: 020 3405 0205

deepmatter@almapr.co.uk

 

About DeepMatter:

 

DeepMatter's long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics. In the near term this involves the provision of an integrated software, hardware and artificial intelligence enabled platform, DigitalGlassware™, to scientists across research and process development sectors.

 

The DigitalGlassware™ platform allows chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. The platform is designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made faster.

 

Chief Executive's Statement

 

Overview

Having now led the DeepMatter team for over a year, I am pleased to report that we are continuing to progress at pace and in line with our strategic roadmap. We are working towards an objective which will see the disruption of an industry, and we reached several key milestones over the six-month reporting period on our journey towards that goal.

 

These milestones include the completion of an equity placing which raised approximately £4.0m, the acquisition of InfoChem GmbH, and the strengthening of our management team and operational structure with two key Board appointments and the appointment of David Cleevely and Professor Lee Cronin as Chairman and member respectively to the Group's Advisory Committee.

 

Post-period end, we also announced our first revenue generating contract for the DigitalGlassware™ platform and launch of the open access DigitalGlassware™ online portal, both key milestones on the road to a wide deployment of our technology across the industry, as well as our increasing international footprint. 

 

DeepMatter's aim is for its platform to become integral to research and process chemistry, providing those involved with a cost-effective, easy-to-use solution that will save them significant time, effort and money. The research industry is ripe for modernisation, and we are confident that our technology, positioning and capability mean that we are able to capitalise on this opportunity.  The Group's vision remains to progress its platform to enable the use of artificial intelligence in chemistry, ultimately to the stage where chemicals can be synthesised autonomously through robotics operating on the DeepMatter platform.

 

DigitalGlasswareTM platform

In the near term, we are delivering an integrated software, hardware and machine learning enabled platform, DigitalGlassware™, to scientists across research and process development sectors. Our immediate focus will be on the marketing of our DigitalGlassware™ platform to the pharmaceutical, life science and contract research industries.

The DigitalGlassware™ platform allows experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. The platform is designed to enable scientists to collaborate effectively; sharing the details of their experiments from anywhere and in real-time. This ensures that work is not needlessly duplicated; time and money wasted; and ultimately new discoveries can be made faster.

 

The Pioneer Programme, launched in May 2018, is expected to complete by the year end. Our seven global partners, which include multinational life sciences companies, research institutions and leading academic institutions, have worked with us to guide the testing and enhancement of our technology. This process has provided us with valuable insights, expert feedback and given us confidence that the product is now fit for purpose on a wider scale. We would like to thank them all for joining us on this important stage of our growth journey.

 

As expected, the Group has also begun to identify unique chemistry insights, which it will use to create intellectual property and share with the wider scientific community in due course, as further proof of the validity of the platform. For example, correlating reaction yields and purities to multiple features recorded in data to determine which features are significant in changing synthesis outcomes. Through these efforts, the potential of the DigitalGlassware™ technology is gaining recognition in the scientific community.

 

To date, the DigitalGlassware™ platform has been used to collect data from over 1,100 days of chemistry research across over 2000 individual experimental runs. Data has been collected and structured, comprising nearly 17 billion sensor readings over 400 million samples. Of the most frequently used synthetic reaction types in medicinal chemistry*, the majority are now represented in the DigitalGlassware™ platform to one extent or another.

 

*as reported in the frequently cited publication by Brown and Boström of pharmaceutical company AstraZeneca in the Journal of Medicinal Chemistry 59, 4443 (2016) 

 

First revenue-generating purchase order

Building upon the DigitalGlassware™ Pioneer Programme, the Group is focused on deploying its technology to an increasingly large user base and continuing to commercialise the platform.

 

A major milestone for the Group in its goal towards monetisation was achieved post-period end with its first revenue-generating purchase order for the DigitalGlassware™ platform from o2h discovery, an Anglo-Indian medicinal chemistry service provider. Having participated in the Pioneer Programme, and being impressed by the DigitalGlassware™ technology, o2h has elected to pay for the provision of a greater number of user licences for deployment across one of its laboratories.

 

Launch of DigitalGlassware™ online portal

In August 2019 we launched our open access DigitalGlassware™ online portal in order to facilitate the distribution of the platform to a wider audience, outside of commercial users.  The portal allows the scientific world to view and interact with the uniquely contextualised, rich and real-time data originated from chemistry lab experiments conducted using DeepMatter's proprietary technology.  Paying clients of the DigitalGlassware™ platform are able to nominate which data remains proprietary, for their sole use, and which can be made shareable via the online portal. The portal is important to showcase how DigitalGlassware™ works under real reaction scenarios and, crucially, how it can save time and money and increase lab productivity. Since the launch of the portal, the Company has observed a 72% increase in social media following and an 131% increase of visitors per week to deepmatter.io.

InfoChem GmbH

In February 2019 we completed the acquisition of InfoChem GmbH a specialist in cheminformatics, from global publisher Springer-Verlag GmbH ("Springer Nature"). The total consideration payable was £2.031 million satisfied as to £0.321 million (€0.374 million) in cash and 68,400,000 new ordinary shares in the capital of the Group.

 

This acquisition was critical to the accelerated development of the DigitalGlasswareTM platform, immediately bringing cost effective access to extensive scientific expertise, established data sources and chemical information software tools to the Group. Integration of these capabilities has begun well, and we expect to see significant further progress in the second half.

 

ICSynth™: innovative retro-synthesis tool

InfoChem's lead software product, ICSynth™, is a key asset for the Group. This desktop machine learning based synthesis design tool reduces costs and identifies unique choices for chemical reactions. The Synthesis Planning market is growing rapidly, and we see a strong opportunity to take market share with this product which, unlike peers, allows retrosynthesis prediction for novel molecules, in-house installation using our customers' knowledge model and the use of any reaction database as a knowledge model. An update to the tool will be released in Q4 2019, rich in new features followed by the launch of an advanced user interface by Q2 2020.

SICM divestment

In January 2019, the Company announced that its subsidiary, OpenIOLabs Limited, had disposed of Scanning Ion Conductance Microscope, by way of an asset purchase agreement. The Group acquired OpenIOLabs in 2017 to secure access to some of its key technology assets. With this objective complete, the remainder of the OpenIOLabs business, being non-core to the Group's continuing operations, was sold for cash to Scientific Digital Imaging Plc.

Strengthened Financial and Operational structure

Placing

During the period, we completed a placing to raise approximately £4.0 million through the issue of a total of 160,185,680 shares at 2.5 pence per share. Since then, the proceeds have begun to be used, to further finance ongoing DigitalGlassware™ technology development, including integration of cheminformatics capabilities, user and partner support, marketing, data science initiatives, manufacture of hardware and for working capital requirements of the enlarged Group. These funds have greatly strengthened the business and we would like to thank all the new and existing investors who took part for their support.

The integration of InfoChem has financially bolstered the business and will see DeepMatter benefit from recurring revenues and an additional sales channel.

Board appointments

There have been two key Board appointments during the period. Following the InfoChem acquisition, Bettina Goerner, Managing Director Database Research Group at Springer Nature, was appointed as a Non-Executive Director in March 2019. This was followed by the appointment of Lauren Lees as Financial Director on 28 June 2019, taking over the role from Michael Bretherton.

We were delighted to be able to retain the expertise of two of our long-standing PLC Board members, through their appointment to the Advisory Committee, whose role is to develop the Group's strategy and proposition in an innovative, interdisciplinary context. The Committee comprises David Cleevely, as Chairman, and Professor Lee Cronin. Both have now stepped down from their roles on the Board.

We now benefit from the combination of a Board concentrated on operational and strategic delivery, and an Advisory Committee providing far-sighted knowledge and industry experience. Our previously announced search for a new Non-Executive Chairman remains ongoing.

Financial Review

 

The Group generated its first revenues over the period, a total of £0.22m, from InfoChem's ongoing sales to its established customer base.

 

The Group incurred a continuing operational loss for the six months ended 30 June 2019 of £1.76m (H1 2018: loss from operations of £0.91m) which after tax and discontinued operations of SICM, resulted in an overall after-tax loss of £1.62m (H1 2018: loss of £0.98m). This was broadly in line with the Board's expectations as the Group continues to commercialise the DigitalGlassware ™ platform and integrates cheminformatic capabilities.

 

In the current financial period, the Group has reviewed and aligned the revenue recognition polices adopted upon the acquisition of InfoChem GmbH with those of the Group and 'IFRS 15 - Contracts with Customers'. The review resulted in changes being made to the revenue recognised upon acquisition and full disclosure will be made of the impact of these changes in the consolidated annual financial statements of the Group for the year ending 31 December 2019.

 

The Group held cash balances at 30 June 2019 of £4.08m (30 June 2018: £2.07m) compared to £1.09m at 31 December 2018. The £2.99m increase in cash during the half year is attributable to the proceeds raised from the placing of shares offset by the continuing investment in the operations of the Group.

 

Outlook

 

Thus far, 2019 is progressing to plan, with the Group's focus on driving deployment with key opinion leaders bearing fruit. We are engaging with a number of industry participants and look forward to updating shareholders in due course.

 

Our plan to deliver the first complete site rollout to early adopters is well underway, with the o2h deployment now complete. We are excited by the scale of the pipeline of opportunities we have built and are focused on the effective execution of wider deployment and further monetisation of the DigitalGlassware™ platform.

We continue to see the platform developing during the year as further cheminformatics capabilities are integrated and the expanding dataset demonstrates its value.


We remain confident about the future and, with a robust strategy in place, look forward to driving our vision and achieving our long-term objectives. 

 

 

Mark Warne

Chief Executive Officer

19 September 2019

 

DEEPMATTER GROUP PLC

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS TO 30 JUNE 2019

 

 

6 months ended 30 June

 2019

6 months ended 30 June

 2018

Year ended 31 December 2018

 

(Unaudited)

(Unaudited)

(Audited)

 

£'000

£'000

£'000

Continuing operations

 

 

 

 

 

 

 

 

 

 

Revenue

215

-

-

Cost of Sales

(182)

-

-

 

 

 

 

Gross Profit

33

-

-

 

 

 

 

Research and development costs

(845)

(1,399)

Share based payments

(168)

(3)

(6)

Administrative costs

(781)

(280)

(600)

Operating loss

(1,761)

(2,005)

Finance income

11

6

12

Finance cost

(1)

-

-

Loss before tax

(1,751)

(1,993)

Income tax credit

86

98

180

Loss from continuing operations

(1,665)

(807)

(1,813)

 

 

 

Discontinued Operations

 

 

 

Profit/(loss) from discontinued operations

29

(173)

(104)

Profit on disposal of discontinued operations

14

-

-

Net result from discontinued operations

43

(104)

 

 

 

 

Loss and total comprehensive loss for the period

(1,622)

(980)

(1,917)

 

Other comprehensive income

 

Amounts which may be reclassified to profit or loss

Currency translation differences

34

-

-

Other comprehensive income for the year

34

-

-

 

Total comprehensive loss for the year attributable to equity holders of the company

(1,588)

(980)

(1,917)

 

Loss per share attributable to the equity holders of the Company:

 

 

Basic and diluted loss per share (pence) on continuing operations

(0.25)

(0.15)

(0.33)

Basic and diluted loss per share (pence) on total operations

(0.24)

(0.18)

(0.35)

         

 

DEEPMATTER GROUP PLC

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE SIX MONTHS ENDED 30 JUNE 2019

 

 

Share equity

Share premium

Merger reserve

Share based payment reserve

Shares to be issued reserve

 

 

 

Foreign currency translation reserve

 Retained earnings

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 31 December 2017

55

3,287

5,334

1

204

-

(768)

8,113

Total comprehensive loss for the six months to 30 June 2018

 -

-

-

-

-

-

(980)

(980) 

Transactions with owners;

 

 

 

 

 

 

 

 

Share based payment charge

-

-

-

3

-

-

-

3

Balance at 30 June 2018

55

3,287

5,334

4

204

-

(1,748)

7,136

Total comprehensive loss for the six months to 31 December 2018

-

-

-

-

-

-

(937)

(937)

Transactions with owners;

 

 

 

 

 

 

 

 

Share based payment charge

-

-

-

3

-

-

-

3

Balance at 31 December 2018

55

3,287

5,334

7

204

-

(2,685)

6,202

Loss for the six months to 30 June 2019

-

-

-

-

-

-

(1,622)

(1,622)

Currency Translation differences

-

-

-

-

-

34

-

34

Total comprehensive loss for the six months to 30 June 2019

-

-

-

-

-

34

(1,622)

(1,588)

Transactions with owners;

 

 

 

 

 

 

 

 

Issue of shares for cash

16

3,849

-

-

-

-

-

3,865

Shares to be issued and issuable on acquisition of subsidiary

3

637

-

-

1,070

-

-

1,710

Share based payment charge

-

-

-

168

-

-

-

168

Balance at 30 June 2019

74

7,773

5,334

175

1,274

34

(4,307)

10,357

 

DEEPMATTER GROUP PLC

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 30 JUNE 2019

 

 

 

As at 30 June

As at 30 June

As at 31 December

 

2019

2018

2018

 

(Unaudited)

(Unaudited)

(Audited)

 

£'000

£'000

£'000

Assets

 

 

 

Non-current assets

 

 

 

Intangible assets and goodwill

6,389

4,938

4,914

Investments

3

3

3

Property, plant and equipment

205

32

29

 

6,597

4,973

4,946

Current assets

 

 

 

Inventories

-

27

74

Trade and other receivables

Taxation recoverable

355

86

149

98

152

289

Cash and cash equivalents

4,082

2,066

1,086

 

4,523

2,340

1,601

Liabilities

 

 

 

Current liabilities

 

 

 

Trade and other payables

 (612)

 (177)

 (345)

Lease liabilities

(124)

-

-

 

(736)

(177)

(345)

 

 

 

 

Net current assets

 3,787

 2,163

 1,256

 

 

 

 

Non-current liabilities

(27)

-

-

 

 

 

 

Total net assets

10,357

7,136

6,202

Equity and liabilities

 

 

 

Shareholders' equity

 

 

 

Called up share capital

74

55

55

Share premium

7,773

3,287

3,287

Merger reserve

5,334

5,334

5,334

Shares to be issued reserve

1,274

204

204

Share based payments reserve

175

4

7

Foreign Currency Translation reserve

34

-

-

Retained (deficit) / earnings

(4,307)

(1,748)

(2,685)

Total equity attributable to shareholders of the Company

10,357

7,136

6,202

 

DEEPMATTER GROUP PLC

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE SIX MONTHS ENDED 30 JUNE 2019

 

 

6 months ended 30 June

6 months ended 30 June

Year

 ended 31

December

 
 
 

 

2019

2018

2018

 

 

(Unaudited)

(Unaudited)

(Audited)

 

 

£'000

£'000

£'000

 

Cash flows from operating activities

 

 

 

 

Operating loss from continuing operations

(1,761)

(911) 

(2,005)

 

Profit/loss from discontinued operations

29

(173)

(213)

 

Adjustments for:

 

                

              

 

Depreciation and amortisation charges

119

28

59

 

Share based payments charge

168

3

6

 

Operating cash outflows before movement in working capital

(1,445)

(1,053)

(2,153)

 

(Increase)/decrease in inventories

74

(17)

(64)

 

(Increase)/decrease in trade and other receivables

(24)

(22)

(25)

 

(Decrease)/increase in trade and other payables

32

(104)

64

 

Cash used in operations

(1,363)

(1,196)

(2,178)

 

Interest received

11

6

12

 

Taxation received

289

-

-

 

Net cash used in operating activities

(1,063)

(1,190)

(2,166)

 

Cash flows from investing activities

 

 

                

 

Purchase of property, plant and equipment

(5)

(9)

(13)

 

Capitalisation of development costs

(38)

-

-

 

Cash and bank in subsidiary at acquisition net of cash payment

267

-

-

 

Net cash used in investing activities

224

(9)

(13)

 

Cashflows from financing activities

Proceeds from issue of share capital

3,865

-

-

 

Payment of lease liabilities

(30)

-

-

 

Cash generated from financing activities

3,835

-

-

 

Net increase/(decrease) in cash and cash equivalents

2,996

(1,199)

(2,179)

 

Cash and cash equivalents at beginning of period

1,086

 3,265

3,265

 

Cash and cash equivalents at end of period

4,082

2,066

1,086

 

 

DEEPMATTER GROUP PLC

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED 30 JUNE 2019

 

1) BASIS OF PREPARATION

The condensed interim financial statements of DeepMatter Group Plc are unaudited condensed consolidated financial statements for the six months ended 30 June 2019. These include unaudited comparatives for the six months ended 30 June 2018 together with audited comparatives for the year ended 31 December 2018.

The interim financial statements do not include all of the information required for full annual financial statements and do not comply with all the disclosures in IAS 34 'Interim Financial Reporting' and should be read in conjunction with the Group's annual financial statements as at 31 December 2018. Accordingly, whilst the interim statements have been prepared in accordance with IFRS, they cannot be construed as being in full compliance with IFRS.

The financial information for the year ended 31 December 2018 does not constitute statutory financial statements within the meaning of section 435 of the Companies Act 2006. A copy of the audited financial statements for that year has been delivered to the Registrar of Companies. The Auditors' opinion on those financial statements was unqualified, did not draw attention to any matters by way of an emphasis of matter paragraph, and it contained no statement under section 498(2) or section 498(3) of the Companies Act 2006.

The accounting policies adopted are consistent with those followed in the preparation of the Group's annual financial statements for the year ended 31 December 2018, with the exception of the adoption of IFRS 16 and changes to accounting policies for IFRS 15, IFRS 8, IFRS 2 and IAS 21. The Group has not early adopted any other standard, interpretation or amendment that has been issued but is not yet effective.

Going concern

Information on the business environment, financial position and the factors underpinning the Group's future prospects and portfolio are included in the Chief Executive's Statement. The Directors confirm that they are satisfied that the Group has adequate resources to continue in business based on the current liquid resources available. For this reason, they continue to adopt the going concern basis in preparing the financial statements.

 

2) SIGNIFICANT ACCOUNTING POLICIES

The accounting policies adopted are consistent with those followed in the preparation of the consolidated annual financial statements of DeepMatter Group Plc for the year ended 31 December 2018 with the exception of the adoption of IFRS 16.

The impact of the alignment of accounting policies following the acquisition of InfoChem GmbH will be disclosed in full in the consolidated annual financial statements of the Group for the year ending 31 December 2019.

Changes in accounting policies applied to IFRS 15, IFRS 8, IFRS 2 and IAS 21.

IFRS 15 - Revenue from Contracts with Customers

The core principle of IFRS 15 is that an entity should recognise revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to exchange for those goods or services.

In the current financial year, the Group carried out a review to align the revenue recognition policies of InfoChem GmbH with those of the Group and 'IFRS 15 Revenue from Contracts with Customers'. The following assessment and changes were made;

·    Software licenses, which upon acquisition, were previously deferred and recognised over the software license term, are now recognised upfront where the performance obligation is satisfied upon the delivery of the license to the customer impacting revenue and deferred revenue disclosed within trade and other payables and accrued income disclosed within other debtors.

·    Hosted software licenses, which were deferred over the license term, continue to be recognised in line with the satisfaction of the performance obligation over the license term and revenue not yet earned is accounted for within deferred income.

·    Software services and maintenance, which, upon acquisition, were previously recognised on completion of the performance obligation, are now recognised in line with the satisfaction of the performance obligation over the contract term impacting accrued income disclosed within other debtors.

·    Project and consulting work, which, upon acquisition, were recognised on completion of the relevant performance obligations continue to be recognised on completion of the relevant performance obligations.

 

Full disclosure of the revenue recognition model applied under IFRS 15 will be made in the consolidated annual financial statements of the Group for the year ending 31 December 2019.

IFRS 16 - Leases

In the current financial year, the Group has adopted IFRS 16 Leases which has resulted in the Group recognising a right-of-use asset and lease liability for all contacts that are or contain a lease.  The Group has applied the modified retrospective adoption method, with no restatement of prior year comparatives. Full disclosure of the accounting policy in respect of IFRS 16 will be made in the consolidated annual financial statements of the Group for the year ending 31 December 2019.

IFRS 2 - Share-based Payments

During the period ending 30 June 2019, options were granted to Mark Warne over 25,000,000 ordinary shares at an exercise price of 2.5 pence, reflecting the 2.5 pence issue price of the placing of shares issued between the 12 and 13 March 2019 to raise gross cash proceeds of £4 million. Provided Mark remains an employee, his options vest over 36 months starting from the commencement of his employment but subject to specific share price triggers being reached. All unexercised options lapse after 10 years from the date of grant. No other directors have been granted share option awards.

Full disclosure of the accounting policy adopted will be made within the consolidated annual financial statements of the Group for the year ending 31 December 2019.

IAS 21 - Foreign currency transactions

As required by IAS 21, the results and financial position of all Group entities that have a functional currency different from the presentation currency are translated in the presentation currency as follows;

·    Assets and liabilities for each statement of financial position presented are translated at the closing rate at the date of the statement of financial position

·    Income and expenses for each income statement are translated at average exchange rates; and

·    All resulting exchange differences are recognised as a separate component of equity in the foreign currency translation reserve.

 

3) SEGMENTAL REPORTING

Operating Segments

The Chief Operating Decision Maker has been identified as the Chief Executive Officer ("CEO") of the company. The Group has two operating segments and the CEO reviews the Group's internal reporting which recognises these two segments in order to assess performance and allocate resources. The Group has determined its reportable segments which are also its operating segments based on these reports.

The Group currently has two operating and reportable segments being DeepMatter and InfoChem;

·    DeepMatter - this segment owns, develops and is in the early stage of commercially exploiting intellectual property, software, hardware and data analysis capabilities (including machine learning) combined as a visionary, disruptive platform called DigitalGlassware, enabling step changes in productivity and discovery for scientists in the pharma and life science sectors.

·    InfoChem - this segment develops and commercialises cheminformatics software to handle, store and retrieve chemical structures and reactions for application in pharma, life sciences and scientific publications. The segment has industry established market leading tools for the production of synthesis planning and reaction prediction solutions and the automatic extraction of scientific information from text and images.

 

Information regarding the operation of the reportable segments is included below. The CEO assesses the performance of the operating segments based on revenue and a measure of earnings before interest, tax, depreciation and amortisation (EBITDA) before any allocation of Group overheads, charges for share based payment and costs associated with acquisitions. This segment EBITDA is used to measure performance as the CEO believes such information is most relevant in evaluating the results of the segment.

The Group's EBITDA for the year has been calculated after deducting the Group overheads from the EBITDA of the two segments as reported internally. Group overheads include the cost of the Board, listing costs, all the costs of running the premises in Glasgow and Munich, Group marketing, finance and legal and professional fees.

The segment information is prepared using accounting policies consistent with those of the Group as a whole.

The assets and liabilities of the Group are not reviewed by the chief operating decision-maker on a segment basis and therefore none of the Group's assets and liabilities are segmental assets and liabilities and are all unlocated for segmental disclosure purposes. For that reason, the Group has not disclosed details of segmental assets and liabilities.

The discontinued operations of SICM which was disposed of on the 15 January is not reviewed by the chief operating decision maker and has therefore not been disclosed within operating segments.

In the six-month period ended 30 June 2019, the Group had 4 customers that exceeded 10% of total revenue, being 21%, 18%, 13% and 12%.

All segments are continuing operations.

 

Revenue by Operating Segment

 

 

6 months ended 30 June 2019

6 months ended 30 June 2018

Year ended 31 December 2018

 

(Unaudited)

(Unaudited)

(Audited)

 

External

Internal

Total

External

Internal

Total

External

Internal

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

DeepMatter

-

-

-

-

-

-

-

-

-

InfoChem

222

-

222

-

-

-

-

-

-

Revenue for the period

222

-

222

-

-

-

-

-

-

 

 

Profit by Operating Segment

 

6 months ended 30 June 2019

6 months ended 30 June 2018

Year ended 31 December 2018

 

(Unaudited)

(Unaudited)

(Audited)

 

EBITDA before share based payments and acquisition costs

Depreciation, amortisation, acquisition costs & share based payments

Operating Profit/(loss)

EBITDA before share based payments and acquisition costs

Depreciation, amortisation, acquisition costs & share based payments

Operating Profit/(loss)

EBITDA before share based payments and acquisition costs

Depreciation, amortisation, acquisition costs & share based payments

Operating Profit/(loss)

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

DeepMatter

(736)

(30)

(766)

(671)

(28)

(699)

(1,464)

(59)

(1,523)

InfoChem

(224)

(89)

(313)

-

-

-

-

-

-

Group overheads

(472)

-

(472)

(209)

-

(209)

(476)

-

(476)

Acquisition costs

-

(42)

(42)

-

-

-

 -

-

-

Share based payments

-

(168)

(168)

-

(3)

(3)

 -

(6)

(6)

Profit before tax and interest

(1,432)

(329)

(1,761)

(880)

(31)

(911)

(1,940)

(65)

(2,005)

Group interest and tax

 

 

96

 

 

104

 

 

192

Discontinued operations

 

 

29

 

 

(173)

 

 

(104)

Profit on disposal of discontinued operation

 

 

14

 

 

-

 

 

-

Profit for the period

(1,432)

(329)

(1,622)

(880)

(31)

(980)

(1,940)

(65)

(1,917)

 

Group overheads, share based payments, acquisition costs, interest and tax are not allocated to segments.

 

4) LOSS PER SHARE (BASIC AND DILUTED)

Basic earnings or loss per share is calculated by dividing the gain or loss attributable to ordinary shareholders by the weighted average number of ordinary shares in issue during the period.

For diluted earnings or loss per share, the weighted average number of ordinary shares in issue is adjusted to assume conversion of all dilutive potential ordinary shares.

 

6 months ended 30 June 2019

6 months ended 30 June 2018

Year ended 31 December 2018

 
 

 

(Unaudited)

(Unaudited)

(Audited)

 

Continuing operations

 

 

 

 

Loss attributable to equity holders of the Group (£'000)

(1,665)

(807)

(1,813)

 

Weighted average number of shares in issue ('000)

662,535

550,740

550,743

 

Basic and diluted loss per share (pence)

 (0.25)

 (0.15)

(0.33)

 

Total operations

 

 

 

 

Loss attributable to equity holders of the Group (£'000)

(1,622)

(980)

(1,917)

 

Weighted average number of dilutive shares in issue

662,535

550,740

550,743

 

Basic and diluted loss per share (pence)

(0.24)

(0.18)

(0.35)

 

 

Basic loss per share is based on the loss after tax for the period and the weighted average number of ordinary shares of £0.0001 each in issue during the period. Diluted loss per share is calculated by adjusting the average number of ordinary shares in issue during the period to assume conversion of all dilutive potential ordinary shares. The Company had a total of 74,116,667 potentially issuable dilutive ordinary shares in existence at the 30 June 2019 period end; (31 December 2018: 23,816,667; 30 June 2018: 23,873,334), comprised of 9,316,667 share options,22,000,000 deferred consideration shares issued in relation to the acquisition of OpenIOLabs Limited and 42,800,000 deferred consideration shares issued in  relation to the acquisition of InfoChem GmbH. The 74,116,667 potentially issuable dilutive shares have not been included in the calculations below due to their potential issuance having an effect to reduce loss per share attributable to equity holders.

5) RELATED PARTY TRANSACTIONS

The Group has taken advantage of the exemptions contained within IAS 24 - 'Related Party Disclosures' from the requirement to disclose transactions between Group companies as these have been eliminated on consolidation.

In addition, during the period the Company paid remuneration to the Directors' in accordance with their service contracts and letters of appointment.

6) HALF YEAR FINANCIAL REPORT

A copy of this half year report, as well as the prior year annual statutory accounts, is available on the Company's website at www.deepmattergroup.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR VVLFFKKFFBBE
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.